We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Baxter International Inc. has announced an agreement with Dorizoe Lifesciences Limited (Dorizoe), a full-service global contract research and development (R&D) organization, that will facilitate accelerated development of more than 20 generic injectable p
Central Government has approved the Foreign Direct Investment (FDI) proposal of Baxter Pharmaceutical (Asia) Pte. Limited, Singapore for 100% FDI worth Rs 4020 crore